Johnson & Johnson (JNJ) is a stock that I’ve moved around a bit on in the past few years. I’ve been pretty vehemently bearish at times, but more recently, I’ve been constructive on the stock as I felt the reaction to Q1 was overblown. The stock is up about 10 bucks since then, and while that’s not gangbusters by any means, it does position JNJ for its Q2 report – due out on Tuesday – to be of even greater importance. I’ll outline below my thoughts on how the stock is positioned going into the Q2 report as well as some things I’ll be watching surrounding the report.
